<?xml version="1.0" encoding="UTF-8"?>
<ref id="B46">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ning</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Mo</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Feng</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Min</surname>
    <given-names>Y. Q.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hou</surname>
    <given-names>D.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2019</year>). 
  <article-title>Interferon-Î³-directed inhibition of a novel high-pathogenic phlebovirus and viral antagonism of the antiviral signaling by targeting STAT1</article-title>. 
  <source>Front. Immunol.</source>
  <volume>10</volume>:
  <fpage>1182</fpage>. 
  <pub-id pub-id-type="doi">10.3389/fimmu.2019.01182</pub-id>
  <?supplied-pmid 31191546?>
  <pub-id pub-id-type="pmid">31191546</pub-id>
 </mixed-citation>
</ref>
